Periodontal regeneration with 0.3% basic fibroblast growth factor (FGF-2) for a patient with aggressive periodontitis: a case report

J Oral Sci. 2016;58(1):137-40. doi: 10.2334/josnusd.58.137.

Abstract

This case report describes the clinical efficacy of treatment with basic fibroblast growth factor (FGF-2) for periodontal regeneration. A patient with aggressive periodontitis participated in a clinical trial involving administration of 0.3% FGF-2 in comparison with a placebo control. To evaluate the efficacy of FGF-2, standardized radiographs were taken before surgery and at 12, 24, and 36 weeks after FGF-2 treatment. The rate of increase in alveolar bone height was 86.9% at 36 weeks. The 6-year postoperative radiograph showed significant development of alveolar bone in comparison with the first visit. FGF-2 treatment may be effective for periodontal regeneration in cases of aggressive periodontitis. (J Oral Sci 58, 137-140, 2016).

Publication types

  • Case Reports
  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Fibroblast Growth Factor 2 / therapeutic use*
  • Humans
  • Male
  • Periodontitis / diagnostic imaging
  • Periodontitis / drug therapy*
  • Periodontitis / physiopathology
  • Placebos
  • Regeneration

Substances

  • Placebos
  • Fibroblast Growth Factor 2